Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
Up)
Cleveland Biolabs (Nasdaq: CBLI) says Michael Fonstein will step down as the company's CEO, however will remain as President. The company has named COO Yakov Kogan as the interim CEO.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- AngioDynamics (ANGO) Appoints George Bourne as Tech Chief
- Southern Co. (SO) Appoints Mark Crosswhite as COO; Makes Other Exec Moves
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
